UC-San Diego: Synergistic Treatment Approach Supercharges Cancer Immunotherapy
August 01, 2025
August 01, 2025
LA JOLLA, California, Aug. 1 (TNSjou) -- The University of California San Diego campus issued the following news:
* * *
Synergistic Treatment Approach Supercharges Cancer Immunotherapy
By Miles Martin
Head and neck squamous cell carcinomas (HNSCC) are a group of cancers that affect cells in and around our mouth and nose. With 890,000 new cases and 450,000 deaths annually, HNSCC accounts for roughly 4.5% of cancer diagnoses and deaths worldwide. . . .
* * *
Synergistic Treatment Approach Supercharges Cancer Immunotherapy
By Miles Martin
Head and neck squamous cell carcinomas (HNSCC) are a group of cancers that affect cells in and around our mouth and nose. With 890,000 new cases and 450,000 deaths annually, HNSCC accounts for roughly 4.5% of cancer diagnoses and deaths worldwide. . . .